114 related articles for article (PubMed ID: 8980395)
1. Acceleration of MRP-associated efflux of rhodamine 123 by genistein and related compounds.
Versantvoort CH; Rhodes T; Twentyman PR
Br J Cancer; 1996 Dec; 74(12):1949-54. PubMed ID: 8980395
[TBL] [Abstract][Full Text] [Related]
2. Functional detection of MDR1/P170 and MRP/P190-mediated multidrug resistance in tumour cells by flow cytometry.
Feller N; Kuiper CM; Lankelma J; Ruhdal JK; Scheper RJ; Pinedo HM; Broxterman HJ
Br J Cancer; 1995 Sep; 72(3):543-9. PubMed ID: 7669559
[TBL] [Abstract][Full Text] [Related]
3. A comparison of rhodamine 123 accumulation and efflux in cells with P-glycoprotein-mediated and MRP-associated multidrug resistance phenotypes.
Twentyman PR; Rhodes T; Rayner S
Eur J Cancer; 1994; 30A(9):1360-9. PubMed ID: 7999426
[TBL] [Abstract][Full Text] [Related]
4. Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein.
Versantvoort CH; Broxterman HJ; Bagrij T; Scheper RJ; Twentyman PR
Br J Cancer; 1995 Jul; 72(1):82-9. PubMed ID: 7599070
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of drug transport by genistein in multidrug-resistant cells expressing P-glycoprotein.
Castro AF; Altenberg GA
Biochem Pharmacol; 1997 Jan; 53(1):89-93. PubMed ID: 8960067
[TBL] [Abstract][Full Text] [Related]
6. Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells.
Versantvoort CH; Schuurhuis GJ; Pinedo HM; Eekman CA; Kuiper CM; Lankelma J; Broxterman HJ
Br J Cancer; 1993 Nov; 68(5):939-46. PubMed ID: 8105867
[TBL] [Abstract][Full Text] [Related]
7. Competitive inhibition by genistein and ATP dependence of daunorubicin transport in intact MRP overexpressing human small cell lung cancer cells.
Versantvoort CH; Broxterman HJ; Lankelma J; Feller N; Pinedo HM
Biochem Pharmacol; 1994 Sep; 48(6):1129-36. PubMed ID: 7945406
[TBL] [Abstract][Full Text] [Related]
8. On the relationship between the probenecid-sensitive transport of daunorubicin or calcein and the glutathione status of cells overexpressing the multidrug resistance-associated protein (MRP).
Versantvoort CH; Bagrij T; Wright KA; Twentyman PR
Int J Cancer; 1995 Dec; 63(6):855-62. PubMed ID: 8847145
[TBL] [Abstract][Full Text] [Related]
9. Modulation by (iso)flavonoids of the ATPase activity of the multidrug resistance protein.
Hooijberg JH; Broxterman HJ; Heijn M; Fles DL; Lankelma J; Pinedo HM
FEBS Lett; 1997 Aug; 413(2):344-8. PubMed ID: 9280310
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometry evaluation of the multidrug-resistant phenotype with functional tests involving uptake of daunorubicin, Hoechst 33342, or rhodamine 123: a comparative study.
Lizard G; Roignot P; Maynadie M; Lizard-Nacol S; Poupon MF; Bordes M
Cancer Detect Prev; 1995; 19(6):527-34. PubMed ID: 8925522
[TBL] [Abstract][Full Text] [Related]
11. Detection of activity of P-glycoprotein in human tumour samples using rhodamine 123.
Ludescher C; Thaler J; Drach D; Drach J; Spitaler M; Gattringer C; Huber H; Hofmann J
Br J Haematol; 1992 Sep; 82(1):161-8. PubMed ID: 1358171
[TBL] [Abstract][Full Text] [Related]
12. Modulation by acrolein and chloroacetaldehyde of multidrug resistance mediated by the multidrug resistance-associated protein (MRP).
Manzano RG; Wright KA; Twentyman PR
Clin Cancer Res; 1996 Aug; 2(8):1321-6. PubMed ID: 9816303
[TBL] [Abstract][Full Text] [Related]
13. Comparison of drug accumulation in P-glycoprotein-expressing and MRP-expressing human leukaemia cells.
Davey MW; Hargrave RM; Davey RA
Leuk Res; 1996 Aug; 20(8):657-64. PubMed ID: 8913319
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase inhibitor-induced alterations of drug uptake, cell cycle and surface antigen expression in human multidrug-resistant (Pgp and MRP) promyelocytic leukemia HL-60 cells.
Sedlák J; Hunáková L; Suliková M; Chorváth B
Leuk Res; 1997 May; 21(5):449-58. PubMed ID: 9225074
[TBL] [Abstract][Full Text] [Related]
15. Efficiency of P-glycoprotein-mediated exclusion of rhodamine dyes from multidrug-resistant cells is determined by their passive transmembrane movement rate.
Eytan GD; Regev R; Oren G; Hurwitz CD; Assaraf YG
Eur J Biochem; 1997 Aug; 248(1):104-12. PubMed ID: 9310367
[TBL] [Abstract][Full Text] [Related]
16. P-glycoprotein and multidrug resistance protein activities in relation to treatment outcome in acute myeloid leukemia.
van der Kolk DM; de Vries EG; van Putten WJ; Verdonck LF; Ossenkoppele GJ; Verhoef GE; Vellenga E
Clin Cancer Res; 2000 Aug; 6(8):3205-14. PubMed ID: 10955805
[TBL] [Abstract][Full Text] [Related]
17. Polyaromatic alkaloids from marine invertebrates as cytotoxic compounds and inhibitors of multidrug resistance caused by P-glycoprotein.
Quesada AR; García Grávalos MD; Fernández Puentes JL
Br J Cancer; 1996 Sep; 74(5):677-82. PubMed ID: 8795567
[TBL] [Abstract][Full Text] [Related]
18. Linear and cyclic peptides as substrates and modulators of P-glycoprotein: peptide binding and effects on drug transport and accumulation.
Sharom FJ; Lu P; Liu R; Yu X
Biochem J; 1998 Aug; 333 ( Pt 3)(Pt 3):621-30. PubMed ID: 9677321
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase C isoenzymes, p53, accumulation of rhodamine 123, glutathione-S-transferase, topoisomerase II and MRP in multidrug resistant cell lines.
Utz I; Gekeler V; Ise W; Beck J; Spitaler M; Grunicke H; Hofmann J
Anticancer Res; 1996; 16(1):289-96. PubMed ID: 8615623
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of P-glycoprotein function and expression by kaempferol and quercetin.
Limtrakul P; Khantamat O; Pintha K
J Chemother; 2005 Feb; 17(1):86-95. PubMed ID: 15828450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
